Design Therapeutics, Inc. · NASDAQ:DSGN
Light Irrevocable Trust #1 dated April 22, 2019 reported a 6.90% stake in Design Therapeutics, Inc. (Schedule 13G/A)
Event Dec 31, 2024 · Filed Feb 7, 2025
Light Irrevocable Trust #1 dated April 22, 2019 reported a 6.90% stake in Design Therapeutics, Inc., 3,834,355 shares, as a passive investor on Dec 31, 2024. Filed Feb 7, 2025 (Schedule 13G/A).
- Stake
- 6.90%
- Shares
- 3,834,355
- Intent
- Passive
- What changed
- Stake changed
- Filed together
- 2 holders
The filing in full
| Holder | Stake | Shares |
|---|---|---|
| Light Irrevocable Trust #1 dated April 22, 2019 | 6.90% | 3,834,355 |
| Jason Howerton | 0% | 0 |
Source
Related
- Design Therapeutics, Inc.
- Light Irrevocable Trust #1 dated April 22, 2019
- Design Therapeutics, Inc. shareholders
- Schedule 13G · Sirenia Capital Management LP · Aug 14, 2026
- Schedule 13G/A · Point72 Asset Management, L.P. · Aug 14, 2026
- Schedule 13G · Point72 Asset Management, L.P. · Jun 9, 2026
- Schedule 13G/A · Point72 Asset Management, L.P. · May 15, 2026
- Schedule 13D/A · SR One Capital Fund I Aggregator, LP · Mar 11, 2026